348 related articles for article (PubMed ID: 38380073)
1. Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.
Igder S; Zamani M; Fakher S; Siri M; Ashktorab H; Azarpira N; Mokarram P
Dis Markers; 2024; 2024():9943412. PubMed ID: 38380073
[TBL] [Abstract][Full Text] [Related]
2. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
3. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis - an update.
Molnár B; Galamb O; Kalmár A; Barták BK; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Dank M
Expert Rev Mol Diagn; 2019 Jun; 19(6):477-498. PubMed ID: 31046485
[No Abstract] [Full Text] [Related]
4. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
6. Circulating Tumor Cells and Cell-free Nucleic Acids as Biomarkers in Colorectal Cancer.
Pourali G; Khalili-Tanha G; Nazari E; Maftooh M; Nassiri M; Hassanian SM; Mobarhan MG; Khazaei M; Ferns G; Avan A
Curr Pharm Des; 2023; 29(10):748-765. PubMed ID: 36892023
[TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy in colorectal cancer: Onward and upward.
Torresan S; de Scordilli M; Bortolot M; Di Nardo P; Foltran L; Fumagalli A; Guardascione M; Ongaro E; Puglisi F
Crit Rev Oncol Hematol; 2024 Feb; 194():104242. PubMed ID: 38128627
[TBL] [Abstract][Full Text] [Related]
8. Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer.
Chen S; Liu T; Bu D; Zhu J; Wang X; Pan Y; Liu Y; Lu ZJ; Wang P
FASEB J; 2021 Jul; 35(7):e21720. PubMed ID: 34110642
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free nucleic acids as biomarkers in colorectal cancer screening and diagnosis.
Tóth K; Barták BK; Tulassay Z; Molnár B
Expert Rev Mol Diagn; 2016; 16(2):239-52. PubMed ID: 26652067
[TBL] [Abstract][Full Text] [Related]
10. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer.
Luo H; Zhao Q; Wei W; Zheng L; Yi S; Li G; Wang W; Sheng H; Pu H; Mo H; Zuo Z; Liu Z; Li C; Xie C; Zeng Z; Li W; Hao X; Liu Y; Cao S; Liu W; Gibson S; Zhang K; Xu G; Xu RH
Sci Transl Med; 2020 Jan; 12(524):. PubMed ID: 31894106
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer.
Kan CM; Pei XM; Yeung MHY; Jin N; Ng SSM; Tsang HF; Cho WCS; Yim AK; Yu AC; Wong SCC
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446204
[TBL] [Abstract][Full Text] [Related]
14. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer.
Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P
Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305
[TBL] [Abstract][Full Text] [Related]
15. Use of Circulating Cell-Free DNA to Guide Precision Medicine in Patients with Colorectal Cancer.
Morris VK; Strickler JH
Annu Rev Med; 2021 Jan; 72():399-413. PubMed ID: 33502901
[TBL] [Abstract][Full Text] [Related]
16. Methylation of FBN1, SPG20, ITF2, RUNX3, SNCA, MLH1, and SEPT9 genes in circulating cell-free DNA as biomarkers of colorectal cancer.
Alizadeh-Sedigh M; Fazeli MS; Mahmoodzadeh H; Sharif SB; Teimoori-Toolabi L
Cancer Biomark; 2022; 34(2):221-250. PubMed ID: 34957998
[TBL] [Abstract][Full Text] [Related]
17. Application and development of noninvasive biomarkers for colorectal cancer screening: a systematic review.
Song D; Wang F; Ju Y; He Q; Sun T; Deng W; Ding R; Zhang C; Xu Q; Qi C; Bao J
Int J Surg; 2023 Apr; 109(4):925-935. PubMed ID: 36974713
[TBL] [Abstract][Full Text] [Related]
18. Genomic and Transcriptomic Research in the Discovery and Application of Colorectal Cancer Circulating Markers.
Ponomaryova AA; Rykova EY; Solovyova AI; Tarasova AS; Kostromitsky DN; Dobrodeev AY; Afanasiev SA; Cherdyntseva NV
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569782
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
Xie W; Xie L; Song X
Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
[TBL] [Abstract][Full Text] [Related]
20. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
